ARID1A mutation + MSI-H
|
LUAD
|
ARID1A mutation + MSI-H
|
LUAD
|
cisplatin + pemetrexed Resistant: C4 – Case Studies
|
cisplatin + pemetrexed Resistant: C4 – Case Studies
|
ARID1A mutation + MSI-H
|
LUAD
|
ARID1A mutation + MSI-H
|
LUAD
|
nivolumab Resistant: C4 – Case Studies
|
nivolumab Resistant: C4 – Case Studies
|
ARID1A mutation + MSI-H
|
LUAD
|
ARID1A mutation + MSI-H
|
LUAD
|
Immunotherapy Resistant: C4 – Case Studies
|
Immunotherapy Resistant: C4 – Case Studies
|